Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TDP-43 post-translational modifications in health and disease
Emanuele Buratti
Expert Opinion on Therapeutic Targets (2018) Vol. 22, Iss. 3, pp. 279-293
Closed Access | Times Cited: 149

Showing 1-25 of 149 citing articles:

ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now?
Rita Mejzini, Loren L. Flynn, Ianthe Pitout, et al.
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 650
Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis
A. Aditya Prasad, Vidhya Bharathi, Vishwanath Sivalingam, et al.
Frontiers in Molecular Neuroscience (2019) Vol. 12
Open Access | Times Cited: 632
TDP-43 α-helical structure tunes liquid–liquid phase separation and function
Alexander E. Conicella, Gregory L. Dignon, Gül H. Zerze, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 11, pp. 5883-5894
Open Access | Times Cited: 327
The role of TDP-43 mislocalization in amyotrophic lateral sclerosis
Terry R. Suk, Maxime W.C. Rousseaux
Molecular Neurodegeneration (2020) Vol. 15, Iss. 1
Open Access | Times Cited: 300
Protein kinase CK2: a potential therapeutic target for diverse human diseases
Christian Borgo, Claudio D’Amore, Stefania Sarno, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 249
The Pathobiology of TDP-43 C-Terminal Fragments in ALS and FTLD
Britt A. Berning, Adam K. Walker
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 171
The debated toxic role of aggregated TDP-43 in amyotrophic lateral sclerosis: a resolution in sight?
Rudolf Hergesheimer, Anna A. Chami, Dênis Reis de Assis, et al.
Brain (2019) Vol. 142, Iss. 5, pp. 1176-1194
Open Access | Times Cited: 163
It’s not just a phase: function and characteristics of RNA-binding proteins in phase separation
Hannah J. Wiedner, Jimena Giudice
Nature Structural & Molecular Biology (2021) Vol. 28, Iss. 6, pp. 465-473
Open Access | Times Cited: 140
Disease‐linked TDP‐43 hyperphosphorylation suppresses TDP‐43 condensation and aggregation
Lara A. Gruijs da Silva, Francesca Simonetti, Saskia Hutten, et al.
The EMBO Journal (2022) Vol. 41, Iss. 8
Open Access | Times Cited: 124
Current State and Future Directions in the Therapy of ALS
Laura Tzeplaeff, Sibylle Wilfling, Maria Viktoria Requardt, et al.
Cells (2023) Vol. 12, Iss. 11, pp. 1523-1523
Open Access | Times Cited: 56
Aggregation of Disordered Proteins Associated with Neurodegeneration
Phoebe S. Tsoi, My Diem Quan, Josephine C. Ferreon, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3380-3380
Open Access | Times Cited: 54
Intra-condensate demixing of TDP-43 inside stress granules generates pathological aggregates
Xiao Yan, David Kuster, Priyesh Mohanty, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 21
Structural Insights Into TDP-43 and Effects of Post-translational Modifications
Liberty François‐Moutal, Samantha Perez‐Miller, David D. Scott, et al.
Frontiers in Molecular Neuroscience (2019) Vol. 12
Open Access | Times Cited: 121
The role of amyloid oligomers in neurodegenerative pathologies
Cameron I. Wells, Samuel Brennan, Matt Keon, et al.
International Journal of Biological Macromolecules (2021) Vol. 181, pp. 582-604
Open Access | Times Cited: 82
Dysregulation of RNA-Binding Proteins in Amyotrophic Lateral Sclerosis
Yuan Chao Xue, Chen Seng Ng, Pinhao Xiang, et al.
Frontiers in Molecular Neuroscience (2020) Vol. 13
Open Access | Times Cited: 73
Post-translational Control of RNA-Binding Proteins and Disease-Related Dysregulation
Alejandro Velázquez‐Cruz, Blanca Baños‐Jaime, Antonio Díaz‐Quintana, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 61
Post-translational modifications on RNA-binding proteins: accelerators, brakes, or passengers in neurodegeneration?
Erin L. Sternburg, Lara A. Gruijs da Silva, Dorothee Dormann
Trends in Biochemical Sciences (2021) Vol. 47, Iss. 1, pp. 6-22
Closed Access | Times Cited: 59
Huntington’s disease mice and human brain tissue exhibit increased G3BP1 granules and TDP43 mislocalization
Isabella Sanchez, Thai B. Nguyen, Whitney England, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 12
Open Access | Times Cited: 56
TDP-43 pathology: From noxious assembly to therapeutic removal
Sean S. Keating, Rebecca San Gil, Molly E. V. Swanson, et al.
Progress in Neurobiology (2022) Vol. 211, pp. 102229-102229
Closed Access | Times Cited: 53
Gene Therapy in Amyotrophic Lateral Sclerosis
Ton Fang, Goun Je, Peter Pacut, et al.
Cells (2022) Vol. 11, Iss. 13, pp. 2066-2066
Open Access | Times Cited: 46
Emerging Therapies and Novel Targets for TDP-43 Proteinopathy in ALS/FTD
Lindsey R. Hayes, Petr Kaláb
Neurotherapeutics (2022) Vol. 19, Iss. 4, pp. 1061-1084
Open Access | Times Cited: 42
Cell environment shapes TDP-43 function with implications in neuronal and muscle disease
Urša Šušnjar, Neva Škrabar, Anna‐Leigh Brown, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 41
The role of altered protein acetylation in neurodegenerative disease
Fariha Kabir, Rachel A.K. Atkinson, Anthony L. Cook, et al.
Frontiers in Aging Neuroscience (2023) Vol. 14
Open Access | Times Cited: 37
Immunotherapy targeting the C-terminal domain of TDP-43 decreases neuropathology and confers neuroprotection in mouse models of ALS/FTD
Tariq Afroz, Elodie Chevalier, Mickaël Audrain, et al.
Neurobiology of Disease (2023) Vol. 179, pp. 106050-106050
Open Access | Times Cited: 24
Protein aggregation and therapeutic strategies in SOD1- and TDP-43- linked ALS
Maria Tsekrekou, Μαρία Γιαννάκου, Katerina Papanikolopoulou, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top